UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

Certification and Notice of Termination of Registration under Section 12(g) of

the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under

Sections 13 and 15(d) of the Securities Exchange Act of 1934.

Commission File Number: 001-33881

 

 

MedAssets, Inc.

(Exact name of registrant as specified in its charter)

 

 

200 North Point Center East, Suite 600

Alpharetta, Georgia 30022

(678) 323-2500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.01 Par Value

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   x
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

Approximate number of holders of record as of the certification or notice date: 0

Pursuant to the requirements of the Securities Exchange Act of 1934, MedAssets, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: February 8, 2016

 

MEDASSETS, INC.
By:   /s/ Christopher Logsdon
  Name: Christopher Logsdon
  Title: Senior Vice President

 

 

 

(MM) (NASDAQ:MDAS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more (MM) Charts.
(MM) (NASDAQ:MDAS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more (MM) Charts.